Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer Dec 13, 2024 10:00AM
Jaguar Health's (JAGX) Napo Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer Jun 20, 2023 08:33AM
Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC) Jun 20, 2023 08:30AM
Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference Jun 15, 2023 08:30AM
Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice Jun 14, 2023 08:30AM


Sep 22, 2022 08:30AM Jaguar Health to Present at Lytham Partners Fall 2022 Investor Conference on September 28th and at Ladenburg Thalmann 2022 Healthcare Conference on September 29th
May 11, 2022 02:30PM TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
Sep 27, 2021 08:30AM Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021
Apr 29, 2021 09:30AM Jaguar Health (JAGX) Announces $10.8 Million Registered Direct Offering for the Benefit of Napo EU Business Plan
Apr 29, 2021 09:29AM Jaguar Health Announces $10.8 Million Registered Direct Offering for the Benefit of Napo EU Business Plan
Apr 15, 2021 08:34AM Jaguar Health (JAGX) Announces Upsizing of At-the-Market Financing Program by $15.3 Million with Ladenburg Thalmann & Co. Inc. for Potential Future Financing Needs
Apr 15, 2021 08:30AM Jaguar Health Announces Upsizing of At-the-Market (ATM) Financing Program by $15.3 Million with Ladenburg Thalmann & Co. Inc. for Potential Future Financing Needs
Jan 13, 2021 08:07AM Jaguar Health (JAGX) Prices 4.438M Share Registered Direct Offering at $3.38/Sh
Jan 13, 2021 08:00AM Jaguar Health Announces $15 Million Registered Direct Offering Priced Above-the-Market Under Nasdaq Rules
Oct 6, 2020 08:30AM Jaguar Health Meets Financial Condition for Sale of Royalty Rights for Mytesi (Crofelemer) Indications
May 22, 2020 09:07AM Jaguar Health (JAGX) Announces Exercise of Warrants for $4.45 Million Gross Proceeds
May 22, 2020 09:00AM Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds
Sep 19, 2019 08:30AM Jaguar Health to Present at Ladenburg Thalmann Healthcare Conference September 24 in New York
Sep 12, 2019 06:35AM Ladenburg Thalmann Starts Jaguar Animal Health (JAGX) at Buy
Jul 23, 2019 04:05PM Jaguar Health Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jul 19, 2019 08:36AM Jaguar Health (JAGX) Prices 1.807M Share Offering at $2/Sh
Jul 18, 2019 08:30AM Jaguar Health Announces Pricing of $14.4 Million Underwritten Public Offering